ARTICLE | Company News
Eisai's fospropofol not approvable
July 26, 2008 1:11 AM UTC
Eisai (Tokyo:4523; Osaka:4523) received a not approvable letter from FDA for an NDA for fospropofol (formerly Aquavan) for use as a sedative-hypnotic agent in adults undergoing diagnostic and therapeu...